--- title: "Is Aegon (ENXTAM:AGN) Pricing Reflect Its Strong Multi Year Share Return Performance" type: "News" locale: "en" url: "https://longbridge.com/en/news/276367766.md" description: "Aegon (ENXTAM:AGN) shares are currently priced at €6.61, raising questions about their value despite a strong multi-year return performance of 8.7% over the past year, 61.5% over three years, and 110.6% over five years. Valuation analyses suggest the stock is undervalued, with an intrinsic value estimated at €21.95 per share, indicating a 69.9% discount. The P/E ratio of 7.86x is below industry averages, further supporting the undervaluation claim. Investors are encouraged to consider Aegon as a potential opportunity based on these insights." datetime: "2026-02-19T18:36:56.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/276367766.md) - [en](https://longbridge.com/en/news/276367766.md) - [zh-HK](https://longbridge.com/zh-HK/news/276367766.md) --- # Is Aegon (ENXTAM:AGN) Pricing Reflect Its Strong Multi Year Share Return Performance - If you are wondering whether Aegon is still offering value at around €6.61 per share, you are not alone. Many investors are asking if the current price properly reflects the business behind the ticker. - Over the past year Aegon shares returned 8.7%, and over 3 and 5 years the stock returned 61.5% and 110.6% respectively. This can change how the market thinks about its risk and return profile, even though the 7 day, 30 day and year to date moves have been close to flat. - Recent coverage around Aegon has focused on its position as a large European insurer and its ongoing presence on investor shortlists for financial stocks. This helps keep attention on how the company is priced. This context matters, because when sentiment and attention shift, price and perceived value often move together. - Aegon currently scores a 5 out of 6 valuation score, which suggests the shares screen as undervalued on most of the checks used here. Next we will walk through those valuation approaches before touching on an even richer way to think about what the stock might be worth. Find out why Aegon's 8.7% return over the last year is lagging behind its peers. ## Approach 1: Aegon Excess Returns Analysis The Excess Returns model looks at how much profit Aegon can generate on its equity above the return that shareholders are assumed to require. Instead of focusing on short term earnings, it asks whether each euro of capital in the business is expected to earn more than its cost over time. For Aegon, the model uses a Book Value of €5.85 per share and a Stable EPS of €0.86 per share, based on weighted future Return on Equity estimates from 7 analysts. The Average Return on Equity used in the model is 14.59%. Against this, the Cost of Equity is €0.32 per share, which implies an Excess Return of €0.54 per share. The Stable Book Value is set at €5.88 per share, again sourced from weighted future Book Value estimates from 7 analysts. Plugging these inputs into the Excess Returns framework produces an estimated intrinsic value of €21.95 per share. Compared with the current share price of around €6.61, this implies the stock screens as materially undervalued based on this approach, with an intrinsic discount of 69.9%. **Result: UNDERVALUED** Our Excess Returns analysis suggests Aegon is undervalued by 69.9%. Track this in your watchlist or portfolio, or discover 224 more high quality undervalued stocks. AGN Discounted Cash Flow as at Feb 2026 Head to the Valuation section of our Company Report for more details on how we arrive at this Fair Value for Aegon. ## Approach 2: Aegon Price vs Earnings For profitable companies, the P/E ratio is a helpful way to see how much investors are paying for each euro of earnings. It links directly to what the business earns today, which many investors find easier to interpret than cash flow or asset based models. What counts as a normal or fair P/E usually reflects two things: how quickly earnings are expected to grow and how risky those earnings appear. Higher expected growth or lower perceived risk can support a higher P/E, while slower growth or higher perceived risk often goes with a lower P/E. Aegon currently trades on a P/E of 7.86x. That sits below the Insurance industry average of about 12.23x and below the peer group average of 13.05x. Simply Wall St’s Fair Ratio for Aegon is 9.80x. This Fair Ratio is a proprietary estimate of what the P/E could be given factors such as Aegon’s earnings profile, industry, profit margins, market size and risk characteristics. Compared with a simple peer or industry comparison, the Fair Ratio is designed to be more tailored, because it adjusts for growth, risk, profitability, sector and market cap rather than assuming one size fits all. On this basis, Aegon’s current P/E of 7.86x sits below the 9.80x Fair Ratio, which indicates that the shares may be undervalued on this metric. **Result: UNDERVALUED** ENXTAM:AGN P/E Ratio as at Feb 2026 P/E ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 103 top founder-led companies. ### Upgrade Your Decision Making: Choose your Aegon Narrative Earlier we mentioned that there is an even better way to understand valuation. Let us introduce Narratives. You write a simple story about Aegon and link it to your own expectations for future revenue, earnings and margins. The Simply Wall St platform on the Community page then turns that story into a financial forecast, a fair value, and an updated view whenever new news or earnings arrive. You can compare that fair value with the current price to help decide whether the stock looks attractive or stretched, and see how different investors can disagree. For example, one Narrative might assume earnings closer to the more bullish €1.7b outlook and lean toward a higher value such as €7.8 per share. Another Narrative might anchor on the more cautious €1.0b view and sit nearer to €5.4. This gives you a clear, side by side sense of how different stories about the same company translate into different numbers. Do you think there's more to the story for Aegon? Head over to our Community to see what others are saying! ENXTAM:AGN 1-Year Stock Price Chart _This article by Simply Wall St is general in nature. **We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.** It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned._ ### **New:** Manage All Your Stock Portfolios in One Place We've created the **ultimate portfolio companion** for stock investors, **and it's free.** • Connect an unlimited number of Portfolios and see your total in one currency • Be alerted to new Warning Signs or Risks via email or mobile • Track the Fair Value of your stocks Try a Demo Portfolio for Free ### Related Stocks - [AEG.US](https://longbridge.com/en/quote/AEG.US.md) - [AEFC.US](https://longbridge.com/en/quote/AEFC.US.md) - [AEGOF.US](https://longbridge.com/en/quote/AEGOF.US.md) ## Related News & Research - [Aegon Leadership Shift And US Move Put Valuation In Investor Focus](https://longbridge.com/en/news/282324054.md) - [Deals of the day-Mergers and acquisitions](https://longbridge.com/en/news/282819779.md) - [Could Investing $50,000 in Broadcom Stock Make You a Millionaire?](https://longbridge.com/en/news/282423907.md) - [09:03 ETAI Isn't the Risk, Human Systems Are: Cross-Industry Signals a Leadership Gap](https://longbridge.com/en/news/282549563.md) - [News Corp details $1B 2025 repurchase program; ~$185.2M bought to date, $117.3M of shares bought on Apr 14](https://longbridge.com/en/news/282823697.md)